Compare QURE & BHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QURE | BHF |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2013 | 2018 |
| Metric | QURE | BHF |
|---|---|---|
| Price | $22.67 | $49.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 7 |
| Target Price | ★ $66.91 | $65.00 |
| AVG Volume (30 Days) | ★ 2.2M | 881.1K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | 23.06 |
| EPS | N/A | ★ 2.84 |
| Revenue | $13,107,000.00 | ★ $6,766,000,000.00 |
| Revenue This Year | $56.20 | $24.61 |
| Revenue Next Year | $357.08 | $1.92 |
| P/E Ratio | ★ N/A | $17.50 |
| Revenue Growth | N/A | ★ 43.23 |
| 52 Week Low | $8.73 | $44.65 |
| 52 Week High | $71.50 | $66.80 |
| Indicator | QURE | BHF |
|---|---|---|
| Relative Strength Index (RSI) | 16.51 | 37.35 |
| Support Level | $21.91 | $48.37 |
| Resistance Level | $27.66 | $64.01 |
| Average True Range (ATR) | 2.17 | 1.70 |
| MACD | -2.39 | 0.19 |
| Stochastic Oscillator | 5.34 | 23.37 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.